We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+17.13%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$31.9B
AUM Growth
+$4.19B
Cap. Flow
+$23.1M
Cap. Flow %
0.07%
Top 10 Hldgs %
18.87%
Holding
1,397
New
111
Increased
494
Reduced
445
Closed
146

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$83.9M
2
QDEL icon
QuidelOrtho
QDEL
+$75.7M
3
GXC icon
State Street SPDR S&P China ETF
GXC
+$73.7M
4
TSLA icon
Tesla
TSLA
+$58.1M
5
MSFT icon
Microsoft
MSFT
+$48.7M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$149M
2
HON icon
Honeywell
HON
+$72.2M
3
IBM icon
IBM
IBM
+$66M
4
INTC icon
Intel
INTC
+$63.3M
5
LMND icon
Lemonade
LMND
+$56M

Sector Composition

Rank Sector Weight
1 Technology 31.17%
2 Healthcare 17.83%
3 Consumer Discretionary 11.58%
4 Financials 10.55%
5 Industrials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRTX
576
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$7.4M 0.02%
33,683
+1,182
+4% +$256K
SYNA icon
577
Synaptics
SYNA
$3.81B
$7.39M 0.02%
76,700
LQD icon
578
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.1B
$7.37M 0.02%
53,364
+4,645
+10% +$633K
VCIT icon
579
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$68.7B
$7.37M 0.02%
75,850
+7,449
+11% +$718K
CSGP icon
580
CoStar Group
CSGP
$12.8B
$7.36M 0.02%
79,640
-22,460
-22% -$1.97M
COHR icon
581
Coherent
COHR
$53.1B
$7.35M 0.02%
96,800
+49,200
+103% +$2.92M
VMRK
582
Vivmark Residential
VMRK
$50.8B
$7.32M 0.02%
123,475
+6,388
+5% +$361K
KTB icon
583
Kontoor Brands
KTB
$3.66B
$7.28M 0.02%
+179,568
New +$6.62M
AFL icon
584
Aflac
AFL
$58.9B
$7.24M 0.02%
162,849
+32,732
+25% +$1.34M
XRX icon
585
Xerox
XRX
$454M
$7.22M 0.02%
311,500
OUT icon
586
Outfront Media
OUT
$4.95B
$7.18M 0.02%
372,965
-5,689
-2% -$96.2K
ALXO icon
587
ALX Oncology
ALXO
$261M
$7.18M 0.02%
83,278
+8,427
+11% +$507K
SNX icon
588
TD Synnex
SNX
$21B
$7.17M 0.02%
88,000
-87,400
-50% -$6.68M
TTEC icon
589
TTEC Holdings
TTEC
$62.6M
$7.17M 0.02%
98,275
+3,900
+4% +$253K
CBRE icon
590
CBRE Group
CBRE
$40.6B
$7.15M 0.02%
114,062
+41,569
+57% +$2.35M
DINO icon
591
HF Sinclair
DINO
$20B
$7.14M 0.02%
276,091
+184,591
+202% +$4.18M
GNTX icon
592
Gentex
GNTX
$4.72B
$7.13M 0.02%
210,000
+6,458
+3% +$199K
TRV icon
593
Travelers Companies
TRV
$78.8B
$7.04M 0.02%
50,189
+7,741
+18% +$994K
CCI icon
594
Crown Castle
CCI
$31.2B
$7.02M 0.02%
44,086
-20,965
-32% -$3.4M
MLKN icon
595
MillerKnoll
MLKN
$1.44B
$6.94M 0.02%
205,200
+163,800
+396% +$5.7M
FLEX icon
596
Flex
FLEX
$39.9B
$6.9M 0.02%
509,037
+26,938
+6% +$311K
RMBS icon
597
Rambus
RMBS
$9.01B
$6.89M 0.02%
394,400
BYD icon
598
Boyd Gaming
BYD
$5.53B
$6.87M 0.02%
+160,000
New +$5.88M
SYNH
599
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$6.83M 0.02%
100,300
+5,200
+5% +$324K
UGI icon
600
UGI
UGI
$8.11B
$6.83M 0.02%
195,400
+18,200
+10% +$637K

Similar funds

Axa's Q4 2020 Portfolio in Review

As of Q4 2020, Axa held 1,397 positions worth $31.9B, up 15% from $27.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q4 2020 filing shows 111 new, 494 increased, 445 reduced and 146 closed positions. Its largest new stake was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M. The largest sale was Linde, an estimated $149M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q4 2020 buy was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M.
  • Axa added most to Amazon in Q4 2020, an estimated $83.9M increase.
  • Axa's biggest Q4 2020 reduction was Linde, cutting an estimated $149M.
  • Axa fully exited Jumia Technologies in Q4 2020, selling an estimated $42.2M.
  • Axa's ten largest holdings make up 19% of its $31.9B portfolio in Q4 2020.
  • Axa opened 111 new positions and closed 146 in Q4 2020.
  • Axa's portfolio value rose 15% quarter-over-quarter to $31.9B.

Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.